Which of the following is false about drugs given in urinary incontinence
**Core Concept**
Urinary incontinence is a complex condition with various causes, including overactive bladder, stress incontinence, and neurological disorders. Management often involves behavioral modifications, pelvic floor exercises, and pharmacological interventions.
**Why the Correct Answer is Right**
The primary goal of pharmacological treatment is to relax the bladder muscle, increase bladder capacity, or enhance sphincter function. Drugs like oxybutynin (an anticholinergic) and tolterodine (a muscarinic receptor antagonist) work by blocking the action of acetylcholine on the bladder muscle, reducing contractions and increasing bladder capacity.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because antidiuretic hormone (ADH) analogs like desmopressin are used to treat nocturnal enuresis, not urinary incontinence in adults.
**Option B:** This option is incorrect because beta-3 adrenergic agonists like mirabegron increase bladder capacity by relaxing the bladder muscle, thus helping to manage overactive bladder symptoms.
**Option C:** This option is incorrect because antimuscarinic agents like fesoterodine and solifenacin are indeed used to treat overactive bladder symptoms, including urinary incontinence.
**Clinical Pearl / High-Yield Fact**
When treating urinary incontinence, it's essential to consider the underlying cause and choose a medication that targets the specific pathophysiological mechanism involved.
**Correct Answer: A. ADH analogs are not used to treat urinary incontinence in adults.**